Pfizer EV/Sales
¿Qué es el EV/Sales de Pfizer?
El EV/Sales de Pfizer Inc. es 3.91
¿Cuál es la definición de EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales de compañías en Sector Health Care en NYSE en comparadas con Pfizer
¿Qué hace Pfizer?
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer and his cousin Charles F. Erhart.
Empresas con ev/sales similar a Pfizer
- China South City tiene EV/Sales de 3.90
- Kering SA tiene EV/Sales de 3.90
- 1414 Degrees tiene EV/Sales de 3.90
- Ryman Hospitality Properties Inc tiene EV/Sales de 3.90
- Adroit Infotech tiene EV/Sales de 3.91
- Meridian tiene EV/Sales de 3.91
- Pfizer tiene EV/Sales de 3.91
- SuperSonic Imagine SA tiene EV/Sales de 3.91
- Nestlé SA tiene EV/Sales de 3.91
- Hang Seng Bank tiene EV/Sales de 3.91
- Wynn Macau tiene EV/Sales de 3.91
- Pinnacle Partners tiene EV/Sales de 3.91
- MercadoLibre Inc tiene EV/Sales de 3.91